|
US4965391A
(en)
|
1987-10-23 |
1990-10-23 |
The University Of Michigan |
Radioiodinated phospholipid ether analogues
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
|
DE4132344A1
(de)
|
1991-09-27 |
1993-04-01 |
Max Planck Gesellschaft |
Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
|
|
US5679647A
(en)
|
1993-08-26 |
1997-10-21 |
The Regents Of The University Of California |
Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
|
|
DE4408011C1
(de)
|
1994-03-10 |
1995-11-02 |
Max Delbrueck Centrum |
Pharmazeutisches Mittel zur Tumortherapie
|
|
WO1998024480A1
(en)
|
1996-12-04 |
1998-06-11 |
The Regents Of The University Of Michigan |
Radioiodinated phospholipid ether analogs and methods of using the same
|
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
|
WO2006014589A2
(en)
|
2004-07-08 |
2006-02-09 |
Cellectar, Llc |
Virtual colonoscopy with radiolabeled phospholipid ether analogs
|
|
US8540968B2
(en)
|
2004-03-02 |
2013-09-24 |
Cellectar, Inc. |
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
|
|
DE602005015687D1
(de)
|
2004-03-02 |
2009-09-10 |
Cellectar Inc |
Phospholipid-analoga für die behandlung von krebs
|
|
US7632644B2
(en)
|
2004-03-02 |
2009-12-15 |
Cellectar, Inc. |
Imaging and selective retention of phospholipid ether analogs
|
|
MX2007007497A
(es)
|
2004-12-20 |
2008-01-11 |
Cellectar Llc |
Analogos de fosfolipido eter para la deteccion y tratamiento del cancer.
|
|
US20070167408A1
(en)
|
2005-12-19 |
2007-07-19 |
Zentaris Gmbh |
Novel alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
|
|
US7893286B2
(en)
|
2007-06-01 |
2011-02-22 |
Cellectar, Inc. |
Method for the synthesis of phospholipid ethers
|
|
US8022235B2
(en)
|
2007-06-01 |
2011-09-20 |
Cellectar, Inc. |
Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use
|
|
CN101878024B
(zh)
|
2007-11-28 |
2014-04-09 |
塞拉特药物股份有限公司 |
改良的紫杉烷递送系统
|
|
US20100120727A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Kyphia Pharmaceuticals, Inc. |
Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
|
|
US20100286510A1
(en)
|
2009-05-11 |
2010-11-11 |
Pinchuk Anatoly |
Use of fluorescent phospholipid ether compounds in biopsies
|
|
WO2010132428A1
(en)
|
2009-05-11 |
2010-11-18 |
Cellectar, Inc. |
Fluorescent phospholipid ether compounds, compositions, and methods of use
|
|
US8871181B2
(en)
|
2009-05-11 |
2014-10-28 |
Cellectar, Inc. |
Fluorescent phospholipid ether compounds, compositions, and methods of use
|
|
US7811548B1
(en)
|
2009-05-11 |
2010-10-12 |
Cellectar, Inc. |
Fluorescent phospholipid ether compounds and compositions
|
|
DK3708192T3
(da)
*
|
2009-06-12 |
2023-11-06 |
Cellectar Inc |
Etherphospholipidforbindelser til behandling af cancer og billeddannelse og detektering af cancerstamceller
|
|
WO2011031919A2
(en)
|
2009-09-11 |
2011-03-17 |
Cellectar, Inc. |
Non-radioactive phospholipid compounds, compositions, and methods of use
|
|
US20140255432A1
(en)
*
|
2011-07-27 |
2014-09-11 |
Ohio State Innovation Foundation |
Silvestrol, silvestrol analogs and uses thereof
|
|
WO2014106826A2
(en)
|
2013-01-07 |
2014-07-10 |
Piramal Enterprises Limited |
Anthracycline analogue and uses thereof
|
|
FR3023290B1
(fr)
|
2014-07-04 |
2016-08-19 |
Pf Medicament |
Derives de flavaglines
|
|
SG11201701565PA
(en)
|
2014-09-03 |
2017-03-30 |
Immunogen Inc |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
CN107708702A
(zh)
*
|
2014-11-17 |
2018-02-16 |
塞勒克塔生物科学有限公司 |
磷脂醚类似物作为靶向癌症的药物载体
|
|
KR102934754B1
(ko)
|
2015-11-25 |
2026-03-04 |
이펙터 테라퓨틱스, 인크. |
Eif4a-억제 화합물 및 이에 관련된 방법
|
|
CN109310702A
(zh)
|
2016-05-20 |
2019-02-05 |
芝加哥大学 |
用于化学疗法、靶向疗法、光动力疗法、免疫疗法和它们的任何组合的纳米颗粒
|
|
JP7043425B2
(ja)
*
|
2016-06-06 |
2022-03-29 |
ジェネンテック, インコーポレイテッド |
シルベストロール抗体-薬物コンジュゲート及び使用方法
|
|
CN109791152B
(zh)
|
2016-06-14 |
2023-03-03 |
塞勒科塔生物科学公司 |
用于鉴定和分离循环肿瘤细胞的磷脂醚类似物
|
|
KR20200015540A
(ko)
|
2017-05-10 |
2020-02-12 |
인사이클 세라퓨틱스, 인코포레이티드 |
α4β7 인테그린을 타겟팅하는 호모데틱 사이클릭 펩타이드
|
|
CA3086454A1
(en)
|
2017-09-26 |
2019-04-04 |
National University Corporation Chiba University |
Radioactive drug
|
|
EP3749317A4
(en)
|
2018-02-07 |
2022-06-22 |
L.E.A.F Holdings Group LLC |
PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES
|
|
WO2019200017A1
(en)
|
2018-04-10 |
2019-10-17 |
Cellectar Biosciences, Inc. |
Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
|
|
CA3097101A1
(en)
|
2018-04-16 |
2019-10-24 |
Nihon Medi-Physics Co., Ltd. |
Modified antibody and radioactive metal-labelled antibody
|
|
MX2022003044A
(es)
*
|
2019-09-12 |
2022-06-02 |
Cellectar Biosciences Inc |
Conjugados de éter de fosfolípido como vehículos de fármacos que focalizan el cáncer.
|
|
KR102973364B1
(ko)
|
2019-10-10 |
2026-06-04 |
셀렉타 바이오사이언시스, 인코퍼레이티드 |
인지질-플라바글린 접합체 및 표적화된 암 치료를 위해 이를 사용하는 방법
|